SCHEMBL31269495

SCHEMBL31269495

Cc1csc(Cn2c(-c3ccc(OCCN4CCNCC4)cc3Cl)nc3c(OC4(C)CC4)ncnc32)n1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.38
▸ DRD2 P14416 5/20 0.35
▸ HRH4 Q9H3N8 5/20 0.35
▸ ALK Q9UM73 1/20 0.32
▸ PRKAB2 O43741 1/20 0.32
▸ PRKAG1 P54619 1/20 0.32
▸ PRKAA2 P54646 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ PRKAG3 Q9UGI9 1/20 0.32
▸ PRKAG2 Q9UGJ0 1/20 0.32
▸ PRKAB1 Q9Y478 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ ESR1 P03372 3/20 0.31
▸ ESR2 Q92731 3/20 0.31
▸ SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983387 0.92 PDE2A (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL31268914 0.90 PDE2A (0.40) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983399 0.90 PDE2A (0.38) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983472 0.90 PDE2A (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983381 0.90 PDE2A (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983501 0.90 PDE2A (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983795 0.88 PDE2A (0.42) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983554 0.88 PDE2A (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL30983419 0.88 DRD2 (0.37) PDE2ADRD2HRH4ALKPRKAB2
SCHEMBL31269459 0.88 DRD2 (0.37) PDE2ADRD2HRH4ALKPRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback